Related Experiment Video

Updated: Jun 26, 2026

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions
09:30

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions

Published on: January 7, 2019

Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1

Y Zhu1, Z Sun, Q Han

  • 1Center for Tissue Engineering, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Peoples Republic of China.

Leukemia
|January 17, 2009
PubMed

Insights

Mesenchymal stem cells (MSCs) inhibit tumor growth via DKK-1, a WNT pathway regulator. NANOG controls DKK-1 in MSCs, impacting K562 cell proliferation and leukemic progenitors.

Area of Science:

  • Stem Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Mesenchymal stem cells (MSCs) exhibit anti-tumor properties, but the underlying mechanisms remain unclear.
  • Understanding MSC-mediated tumor inhibition is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which MSCs inhibit tumor cell proliferation.
  • To identify key molecules involved in MSC-mediated anti-cancer effects.

Main Methods:

  • Investigated the role of dickkopf-1 (DKK-1) secreted by MSCs.
  • Utilized anti-DKK-1 antibodies and RNA interference (RNAi) to modulate DKK-1 levels.
  • Employed Cellmax artificial capillary modules to study MSCs in a humoral microenvironment.
  • Assessed the impact of MSCs on K562 cell proliferation and primary leukemic hematopoietic progenitors.

Main Results:

  • Identified DKK-1 as a key mediator of MSCs' inhibitory effect on K562 cell proliferation.
  • Neutralization or downregulation of DKK-1 attenuated the anti-proliferative effects of MSCs.
  • Demonstrated that NANOG regulates DKK-1 expression in MSCs.
  • Confirmed MSCs inhibit proliferation in a humoral microenvironment and affect primary leukemic cells.

Conclusions:

  • DKK-1 is a crucial molecule through which MSCs exert their tumor-inhibitory effects.
  • NANOG plays a role in regulating MSCs' anti-cancer potential.
  • MSCs possess a general inhibitory capacity on neighboring cells, including malignant ones, contributing to tissue homeostasis.

More Related Videos

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells06:24

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...